m porcinum strain atcc 33776 Search Results


m porcinum atcc 33776 t  (ATCC)
92
ATCC m porcinum atcc 33776 t
M Porcinum Atcc 33776 T, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m porcinum atcc 33776 t/product/ATCC
Average 92 stars, based on 1 article reviews
m porcinum atcc 33776 t - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
ddx52 antibody  (Bio-Techne corporation)
91
Bio-Techne corporation ddx52 antibody
Ddx52 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ddx52 antibody/product/Bio-Techne corporation
Average 91 stars, based on 1 article reviews
ddx52 antibody - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
feature m porcinum atcc 33776 t third biovariant complex isolates atcc baa 328 atcc 49939 clinical  (ATCC)
90
ATCC feature m porcinum atcc 33776 t third biovariant complex isolates atcc baa 328 atcc 49939 clinical
Clinical and geographic locations of the 46 clinical and 2 reference isolates of the selected PRA group of the sorbitol-negative third biovariant complex
Feature M Porcinum Atcc 33776 T Third Biovariant Complex Isolates Atcc Baa 328 Atcc 49939 Clinical, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/feature m porcinum atcc 33776 t third biovariant complex isolates atcc baa 328 atcc 49939 clinical/product/ATCC
Average 90 stars, based on 1 article reviews
feature m porcinum atcc 33776 t third biovariant complex isolates atcc baa 328 atcc 49939 clinical - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
85 60 m phlei atcc 11758 m phlei i m porcinum atcc 33776  (ATCC)
93
ATCC 85 60 m phlei atcc 11758 m phlei i m porcinum atcc 33776
Restriction patterns of 43 reference isolates from 34 Mycobacterium species
85 60 M Phlei Atcc 11758 M Phlei I M Porcinum Atcc 33776, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/85 60 m phlei atcc 11758 m phlei i m porcinum atcc 33776/product/ATCC
Average 93 stars, based on 1 article reviews
85 60 m phlei atcc 11758 m phlei i m porcinum atcc 33776 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
m fortuitum third biovariant sorbitol negative group  (ATCC)
93
ATCC m fortuitum third biovariant sorbitol negative group
Restriction patterns of 43 reference isolates from 34 Mycobacterium species
M Fortuitum Third Biovariant Sorbitol Negative Group, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m fortuitum third biovariant sorbitol negative group/product/ATCC
Average 93 stars, based on 1 article reviews
m fortuitum third biovariant sorbitol negative group - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
anti npc2  (Biorbyt)
88
Biorbyt anti npc2
Restriction patterns of 43 reference isolates from 34 Mycobacterium species
Anti Npc2, supplied by Biorbyt, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti npc2/product/Biorbyt
Average 88 stars, based on 1 article reviews
anti npc2 - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier
anti pjak2 tyr1007 1008  (Cell Signaling Technology Inc)
97
Cell Signaling Technology Inc anti pjak2 tyr1007 1008
Restriction patterns of 43 reference isolates from 34 Mycobacterium species
Anti Pjak2 Tyr1007 1008, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pjak2 tyr1007 1008/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
anti pjak2 tyr1007 1008 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier
anti pjak2 tyr 1007 1008  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc anti pjak2 tyr 1007 1008
Restriction patterns of 43 reference isolates from 34 Mycobacterium species
Anti Pjak2 Tyr 1007 1008, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pjak2 tyr 1007 1008/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti pjak2 tyr 1007 1008 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


Clinical and geographic locations of the 46 clinical and 2 reference isolates of the selected PRA group of the sorbitol-negative third biovariant complex

Journal:

Article Title: Clinical and Laboratory Features of Mycobacterium porcinum †

doi: 10.1128/JCM.42.12.5689-5697.2004

Figure Lengend Snippet: Clinical and geographic locations of the 46 clinical and 2 reference isolates of the selected PRA group of the sorbitol-negative third biovariant complex

Article Snippet: Results for some isolates have previously been published as part of earlier taxonomic studies ( 27 , 32 ). table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Isolate group and feature M. porcinum ATCC 33776 T Third biovariant complex isolates ATCC BAA-328 ATCC 49939 Clinical isolates (no. positive/no. tested) (%) All isolates Pigment (early/late) −/− −/− −/− 0/46 (0) Rough colony morphology + + + 36/46 (78) Growth at: <7 days + + + 46/46 (100) 30°C + + + 46/46 (100) 45°C a (14 days) + + + 14/46 (30) Acetamide + + + 46/46 (100) Carbohydrate utilization d -Mannitol + + + 46/46 (100) i- myo -Inositol + + + 46/46 (100) d -Glucitol (sorbitol) − − − 0/46 (0) l -Rhamnose − − − 0/46 (0) d -Trehalose + − + 35/46 (76) Citrate − − − 0/46 (0) Disk inhibition Polymyxin B (diameter of inhibition, >6 mm) a + + + 46/46 (100) Kanamycin (diameter of inhibition, ≥20 mm) a + − + 17/46 (37) Random isolates Arylsulfatase activity (3 days) + + + 31/31 (100) Semiquantitative catalase (≥100 mm) a − b ND c − 17/17 (100) Catalase (68°C) a + ND + 14/19 (74) Nitrate reduction a − ND + 19/19 (100) Iron uptake a + ND + 18/19 (95) MacConkey agar ND ND + 17/17 (100) Disk inhibition Cephalothin (diameter of inhibition, >6 mm) a − − − 0/29 (0) Open in a separate window a First reported data for clinical isolates and for most tests for the ATCC type strain. b For M. porcinum ATCC 33776 T , the semiquantitative catalase test outcome was weakly positive (the column of bubbles was 65 mm high), a result we considered negative. c ND, not determined.

Techniques: Infection

Laboratory features of clinical and reference isolates of the selected PRA group of the M. fortuitum d -sorbitol-negative third biovariant complex and the ATCC type strain of M. porcinum

Journal:

Article Title: Clinical and Laboratory Features of Mycobacterium porcinum †

doi: 10.1128/JCM.42.12.5689-5697.2004

Figure Lengend Snippet: Laboratory features of clinical and reference isolates of the selected PRA group of the M. fortuitum d -sorbitol-negative third biovariant complex and the ATCC type strain of M. porcinum

Article Snippet: Results for some isolates have previously been published as part of earlier taxonomic studies ( 27 , 32 ). table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Isolate group and feature M. porcinum ATCC 33776 T Third biovariant complex isolates ATCC BAA-328 ATCC 49939 Clinical isolates (no. positive/no. tested) (%) All isolates Pigment (early/late) −/− −/− −/− 0/46 (0) Rough colony morphology + + + 36/46 (78) Growth at: <7 days + + + 46/46 (100) 30°C + + + 46/46 (100) 45°C a (14 days) + + + 14/46 (30) Acetamide + + + 46/46 (100) Carbohydrate utilization d -Mannitol + + + 46/46 (100) i- myo -Inositol + + + 46/46 (100) d -Glucitol (sorbitol) − − − 0/46 (0) l -Rhamnose − − − 0/46 (0) d -Trehalose + − + 35/46 (76) Citrate − − − 0/46 (0) Disk inhibition Polymyxin B (diameter of inhibition, >6 mm) a + + + 46/46 (100) Kanamycin (diameter of inhibition, ≥20 mm) a + − + 17/46 (37) Random isolates Arylsulfatase activity (3 days) + + + 31/31 (100) Semiquantitative catalase (≥100 mm) a − b ND c − 17/17 (100) Catalase (68°C) a + ND + 14/19 (74) Nitrate reduction a − ND + 19/19 (100) Iron uptake a + ND + 18/19 (95) MacConkey agar ND ND + 17/17 (100) Disk inhibition Cephalothin (diameter of inhibition, >6 mm) a − − − 0/29 (0) Open in a separate window a First reported data for clinical isolates and for most tests for the ATCC type strain. b For M. porcinum ATCC 33776 T , the semiquantitative catalase test outcome was weakly positive (the column of bubbles was 65 mm high), a result we considered negative. c ND, not determined.

Techniques: Inhibition, Activity Assay

Susceptibility results for isolates of the selected PRA group of the M. fortuitum sorbitol-negative third biovariant and M. porcinum ATCC 33776 T with the same PRA pattern a

Journal:

Article Title: Clinical and Laboratory Features of Mycobacterium porcinum †

doi: 10.1128/JCM.42.12.5689-5697.2004

Figure Lengend Snippet: Susceptibility results for isolates of the selected PRA group of the M. fortuitum sorbitol-negative third biovariant and M. porcinum ATCC 33776 T with the same PRA pattern a

Article Snippet: Results for some isolates have previously been published as part of earlier taxonomic studies ( 27 , 32 ). table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Isolate group and feature M. porcinum ATCC 33776 T Third biovariant complex isolates ATCC BAA-328 ATCC 49939 Clinical isolates (no. positive/no. tested) (%) All isolates Pigment (early/late) −/− −/− −/− 0/46 (0) Rough colony morphology + + + 36/46 (78) Growth at: <7 days + + + 46/46 (100) 30°C + + + 46/46 (100) 45°C a (14 days) + + + 14/46 (30) Acetamide + + + 46/46 (100) Carbohydrate utilization d -Mannitol + + + 46/46 (100) i- myo -Inositol + + + 46/46 (100) d -Glucitol (sorbitol) − − − 0/46 (0) l -Rhamnose − − − 0/46 (0) d -Trehalose + − + 35/46 (76) Citrate − − − 0/46 (0) Disk inhibition Polymyxin B (diameter of inhibition, >6 mm) a + + + 46/46 (100) Kanamycin (diameter of inhibition, ≥20 mm) a + − + 17/46 (37) Random isolates Arylsulfatase activity (3 days) + + + 31/31 (100) Semiquantitative catalase (≥100 mm) a − b ND c − 17/17 (100) Catalase (68°C) a + ND + 14/19 (74) Nitrate reduction a − ND + 19/19 (100) Iron uptake a + ND + 18/19 (95) MacConkey agar ND ND + 17/17 (100) Disk inhibition Cephalothin (diameter of inhibition, >6 mm) a − − − 0/29 (0) Open in a separate window a First reported data for clinical isolates and for most tests for the ATCC type strain. b For M. porcinum ATCC 33776 T , the semiquantitative catalase test outcome was weakly positive (the column of bubbles was 65 mm high), a result we considered negative. c ND, not determined.

Techniques:

Restriction patterns of 43 reference isolates from 34 Mycobacterium species

Journal:

Article Title: Novel Allelic Variants of Mycobacteria Isolated in Brazil as Determined by PCR-Restriction Enzyme Analysis of hsp65

doi: 10.1128/JCM.40.11.4191-4196.2002

Figure Lengend Snippet: Restriction patterns of 43 reference isolates from 34 Mycobacterium species

Article Snippet: We also determined restriction profiles for M. chelonae subsp. niacinogenes , M. chubuense , and M. komossense , species for which no identification patterns have been reported earlier (Table ). table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Species Strain a Pattern b M. africanum UG MB3 M. tuberculosis complex I M. agri ATCC 27406 235/130/85-160/145/60 M. aichiense ATCC 27280 320/115-195/70/60 M. asiaticum ATCC 25276; RIVM Z26114 M. asiaticum I M. aurum ATCC 23366 441-125/115/70/60 ATCC 23366 320/115-140/95/60/55 M. avium ATCC 25291 M. avium I M. bovis ATCC 19210 M. tuberculosis complex I M. bovis BCG-Moreaux ATCC 35736 M. tuberculosis complex I M. chelonae NCTC 946; UG MB41 M. chelonae I + 60 M. chelonae subsp. niacinogenes ATCC 19237 320/115-175/145 M. chitae ATCC 19627 320/115-140/85/60 M. chubuense ATCC 27278 235/205-140/85/60 M. diernhoferi ATCC 19340 320/115-145/140/60 M. flavenscens ATCC 14474 M. flavescens I + 60 M. fortuitum ATCC 6841 M. fortuitum I + 60/55 M. gordonae ATCC 14470 M. gordonae I M. gordonae ureolyticum RIVM MIS222 M. gordonae III M. intracellulare ATCC 13950 M. intracellulare I M. kansasii ATCC 12478 M. kansasii I M. komossense ATCC 33013 320/115-145/140/60 M. mageritense UAM M. mageritense I M. marinum ATCC 927; RIVM MIS 14 M. marinum I M. neoaurum ATCC 25790 M. neoaurum I -55 M. obuense ATCC 27023 235/205-140/85/60 M. phlei ATCC 11758 M. phlei I M. porcinum ATCC 33776 235/205-140/125/95/55 M. rhodesiae ATCC 27024 320/115-160/125/60 M. simiae ATCC 25275 M. simiae I M. smegmatis ATCC 19420 M. smegmatis I M. smegmatis mc 2 155 Pasteur Institute M. smegmatis I M. szulgai NCTC 10831 M. szulgai I M. terrae ATCC 15755 M. terrae I M. thermoresistibile ATCC 19527 235/205-175/135/70 M. tokaiense RIVM T 47502 235/130/85-140/95/80/60 M. triviale ATCC 23292 M. triviale I M. tuberculosis H37Rv ATCC 27294 M. tuberculosis complex M. tuberculosis H37Ra ATCC 25177 M. tuberculosis complex M. vaccae ATCC 15483 M. vaccae I M. xenopi RIVM MYC527 M. xenopi I Open in a separate window a UG, University of Ghent, Ghent, Belgium; ATCC, American Type Culture Collection, Manassas, Va.; RIVM, National Institute of Public Health and the Environment, Bilthoven, The Netherlands; NCTC, National Collection of Type Cultures; CRPHF, Reference Center for Tuberculosis Professor Hélio Fraga, Rio de Janeiro, Brazil; UAM, Autonomous University of Madrid. b The numbers represent the molecular sizes (in base pairs) of the bands.

Techniques: